Status:
COMPLETED
A Study to Assess the Analgesic Properties of a Sublingual Wafer Formulation of Ketamine Following Third Molar Extraction
Lead Sponsor:
Lotus Clinical Research, LLC
Collaborating Sponsors:
iX Biopharma Ltd.
Conditions:
Pain
Eligibility:
All Genders
18-38 years
Phase:
PHASE2
Brief Summary
This is a Phase 2, randomized, multicenter, parallel group, double-blind, dose-ranging, placebo-controlled evaluation of the analgesic efficacy, safety and pharmacokinetics of ketamine sublingual wafe...
Eligibility Criteria
Inclusion
- 18- 38 years of age Scheduled to undergo two ipsilateral third molar extractions
Exclusion
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2014
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT02199678
Start Date
July 1 2014
End Date
November 1 2014
Last Update
November 21 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Lotus Clinical Research, LLC
Pasadena, California, United States, 91105
2
Prahealthsciences
Salt Lake City, Utah, United States, 84106